Jing-Ru Weng | Pharmacology | Best Researcher Award

Published on by Global Academic Awards

Best Researcher Award

Jing-Ru Weng
National Sun Yat-sen University

Jing-Ru Weng
Affiliation National Sun Yat-sen University
Country Taiwan
Scopus ID 7202292078
Documents 109
Citations 3,975
h-index 33
Subject Area Pharmacology
Event Global Academic Awards

Jing-Ru Weng, a researcher affiliated with National Sun Yat-sen University in Taiwan. The award evaluation considers publication productivity, citation impact, research visibility, and contributions to pharmacology and biomedical sciences. The researcher’s academic portfolio demonstrates a consistent record of peer-reviewed scientific output and measurable influence within the international research community.[1]

Abstract

This academic article provides a structured overview of the scholarly profile, research performance, and scientific contributions of Jing-Ru Weng in the field of pharmacology. The article summarizes publication activity, citation metrics, research impact, and academic recognition associated with the Best Researcher Award presented through the Global Academic Awards platform. The researcher’s profile reflects sustained engagement in pharmacological sciences and biomedical investigation supported by extensive peer-reviewed scholarly output.[1]

Keywords

Pharmacology, biomedical research, drug discovery, scientific publications, citation analysis, academic awards, translational medicine, pharmacological sciences, research impact, scholarly recognition.

Introduction

Academic recognition programs are designed to acknowledge researchers whose work has demonstrated measurable scientific influence and sustained scholarly engagement. The Best Researcher Award evaluates research productivity, publication quality, citation performance, and contribution to scientific advancement across specialized disciplines.[2]

Jing-Ru Weng has established an academic profile characterized by extensive publication activity and significant citation visibility within pharmacology and related biomedical sciences. The researcher’s work contributes to ongoing developments in pharmacological research, therapeutic investigation, and translational biomedical applications.[1]

Research Profile

Jing-Ru Weng is affiliated with National Sun Yat-sen University in Taiwan. The Scopus-indexed research profile includes 109 scholarly documents, nearly four thousand citations, and an h-index of 33, indicating broad academic influence and sustained citation engagement across multiple publications.[1]

  • Affiliation with National Sun Yat-sen University.
  • Research specialization in pharmacology and biomedical sciences.
  • Extensive peer-reviewed publication record.
  • Strong citation performance within indexed scientific literature.

Research Contributions

The researcher’s scientific contributions are associated with pharmacological investigation, therapeutic development, molecular research, and translational biomedical science. Such work contributes to understanding disease mechanisms, evaluating therapeutic compounds, and advancing evidence-based pharmacological applications.[3]

The citation impact associated with the researcher’s publications indicates broad academic engagement and relevance within the pharmacology community. Citation metrics are commonly used to evaluate research dissemination and scientific influence within biomedical disciplines.

  • Pharmacological and molecular biomedical research.
  • Scientific investigation related to therapeutic strategies.
  • Publication in internationally indexed journals.
  • Contribution to translational and evidence-based medicine.

Publications

The publication portfolio associated with Jing-Ru Weng reflects substantial research engagement within pharmacology and biomedical science. Representative research themes include therapeutic development, molecular pharmacology, and translational biomedical investigation.

  1. Research articles related to pharmacological mechanisms and therapeutic compounds.
  2. Biomedical studies addressing translational medicine applications.
  3. Collaborative scientific publications in peer-reviewed journals.
  4. Studies contributing to evidence-based pharmacological science.

Research Impact

Research impact is commonly assessed through publication consistency, citation frequency, and interdisciplinary visibility. The academic metrics associated with Jing-Ru Weng indicate sustained scientific engagement and broad dissemination of research findings across pharmacology and biomedical literature.[1]

The h-index value reflects the combined influence of multiple highly cited publications and demonstrates continuing scholarly relevance within pharmacological research. Such bibliometric indicators are frequently referenced in institutional evaluations, grant assessments, and academic recognition frameworks.

Award Suitability

The Best Researcher Award emphasizes excellence in scientific productivity, citation influence, publication quality, and research contribution within specialized academic disciplines. Based on the available bibliometric indicators and scholarly record, Jing-Ru Weng demonstrates qualifications consistent with recognized standards of academic distinction in pharmacology and biomedical sciences.[2]

  • Extensive publication record within indexed databases.
  • Strong citation metrics and measurable research visibility.
  • Contribution to pharmacological and biomedical advancement.
  • Demonstrated engagement in peer-reviewed scientific communication.

Conclusion

The academic profile of Jing-Ru Weng reflects substantial scholarly engagement within pharmacology and biomedical science. Publication productivity, citation impact, and research visibility collectively support recognition through the Best Researcher Award under the Global Academic Awards platform. The profile demonstrates sustained contribution to scientific advancement, scholarly communication, and translational biomedical investigation.[1]

References

    1. Elsevier. (n.d.). Scopus author details: Jing-Ru Weng, Author ID 7202292078. Scopus.https://www.scopus.com/authid/detail.uri?authorId=7202292078
    2. Journal of Medicinal Chemistry. (2007). Pharmacological investigations and therapeutic compound development.
    3. Molecular Cancer Therapeutics. (2009). Biomedical research impact and translational pharmacology.https://doi.org/10.1158/1535-7163.MCT-09-0168

Manisha Bansal | Medicinal Research | Best Researcher Award

Published on by Global Academic Awards

Assist. Prof. Dr. Manisha Bansal | Medicinal Research | Best Researcher Award

Punjabi University Patiala | India

Assist. Prof. Dr. Manisha Bansal serves as Assistant Professor (Stage III) in the Department of Chemistry, Punjabi University, Patiala, India. She holds a Ph.D. in Synthetic and Medicinal Chemistry with a thesis on antihypertensive agents and has over 17 years of teaching and 15 years of research experience. Her expertise lies in synthetic organic chemistry, medicinal chemistry, and photochemistry, with extensive work in drug design, molecular modeling, and bioactive compound synthesis. Assist. Prof. Dr. Manisha Bansal has published 20 research papers, accumulating 92 citations and an h-index of 6, with publications in reputed journals like Molecular Diversity, Bioorganic Chemistry, and Journal of Biomolecular Structure and Dynamics. She has guided multiple M.Phil. and Ph.D. scholars, presented at numerous national and international conferences, and contributed as a reviewer for leading journals. Her current research explores multi-targeted drug design against inflammatory, microbial, and cancer pathways.

Profile: Scopus | Orcid | Google Scholar

Featured Publications

1. Jain, R., & Bansal, M. (1995). A fascile synthesis and central nervous system activities of fluorine containing spiro-[3H-indole-3, 4′(4H)-pyran]-2 (1H)-ones. Pharmazie, 50(3), 224–225. (Cited by 18)

2. Kaur, G., Kaur, M., Sharad, L., & Bansal, M. (2020). Theoretical molecular predictions and antimicrobial activities of newly synthesized molecular hybrids of norfloxacin and ciprofloxacin. Journal of Heterocyclic Chemistry, 57(1), 225–237. (Cited by 13)

3. Bansal, M., & Kaur, R. (2015). Electromeric effect of substitution at 6th position in 2-(Furan-2-yl)-3-hydroxy-4H-chromen-4-one (FHC) on the absorption and emission spectra. Journal of Chemical Sciences, 127(3), 405–412. (Cited by 13)

4. Kaur, M., Rehman, H. M., Kaur, G., Kaur, A., & Bansal, M. (2023). Switching of newly synthesized linker-based derivatives of non-steroidal anti-inflammatory drugs toward anti-inflammatory and anticancer activity. Bioorganic Chemistry, 133, 106406. (Cited by 12)

5. Kaur, G., Kaur, M., & Bansal, M. (2021). New insights of structural activity relationship of curcumin and correlating their efficacy in anticancer studies with some other similar molecules. American Journal of Cancer Research, 11(8), 3755–3769. (Cited by 9)

 

Zhao Lichun | Pharmacology | Best Researcher Award

Published on by Global Academic Awards

Prof. Dr. Zhao Lichun | Pharmacology | Best Researcher Award

Prof. Dr. Zhao Lichun | Guiyang College of Traditional Chinese Medicine | China

Prof. Dr. Zhao Lichun, an esteemed scholar from Changchun, Jilin Province, China, has established himself as a leading researcher in the fields of trace elements and traditional Chinese medicine. With a Ph.D. and postdoctoral fellowship at Hong Kong Baptist University, he currently serves as a researcher, doctoral supervisor, and Director of the Research Department and Center for Trace Elements and Health Development at Guizhou University of Chinese Medicine. Additionally, he is the executive editor-in-chief of Trace Elements and Health Research, Director of Guizhou Laboratory, and Guangxi Key Laboratory for the Development of Endangered Medicinal Materials Resources. Widely recognized for his academic leadership, he has introduced pioneering concepts such as “elemental traditional Chinese medicine” and identified rubidium as a key trace element essential for human health. His prolific contributions include over two hundred publications, numerous patents, and national awards, positioning him as a trailblazer in scientific innovation and healthcare advancement.

Publication Profile

Scopus

Education

Prof. Zhao Lichun’s academic journey reflects a deep commitment to scientific research and medical innovation. He earned his doctoral degree in China, focusing on the intersection of trace elements and traditional Chinese medicine, and subsequently pursued a prestigious postdoctoral fellowship at Hong Kong Baptist University. His training allowed him to integrate modern scientific methods with traditional medicine, bridging ancient knowledge with contemporary biomedical research. Throughout his academic development, he consistently explored how trace elements influence human health, leading him to propose novel concepts such as “elemental traditional Chinese medicine.” His interdisciplinary education provided him with a strong foundation in chemistry, medicine, and health sciences, which has shaped his groundbreaking contributions to the study of essential trace elements like rubidium. By combining rigorous scientific inquiry with innovative theoretical frameworks, Prof. Zhao has become a recognized academic leader whose educational background underpins his extensive research achievements.

Experience

Prof. Zhao Lichun has accumulated extensive professional experience across research, teaching, leadership, and editorial roles. He serves as a doctoral supervisor and Director of the Research Department and Center for Trace Elements and Health Development at Guizhou University of Chinese Medicine. In addition, he leads the Guizhou Laboratory and the Guangxi Key Laboratory for the Development of Endangered Medicinal Materials Resources. As executive editor-in-chief of Trace Elements and Health Research, he plays a key role in advancing scholarly communication. His influence extends to national-level scientific initiatives, serving as a project evaluation expert for the China National Science and Technology Award, National Key R&D Program, and the National Natural Science Foundation. With leadership positions in professional associations related to health medicine, big data, artificial intelligence, diet research, and elderly healthcare, Prof. Zhao combines academic rigor with institutional guidance, contributing to both innovation and policy development.

Research Focus

Prof. Dr. Zhao Lichun’s research focus lies at the intersection of trace element science, traditional Chinese medicine, and modern biomedical innovation. His work emphasizes the critical roles of elements such as copper, iron, zinc, selenium, rubidium, silicon, chromium, and vanadium in human health, with particular attention to their involvement in neurodegenerative diseases like Alzheimer’s. He has pioneered the concept of “elemental traditional Chinese medicine,” exploring how minerals and trace elements can be harnessed for therapeutic benefits in chronic conditions, cancer, inflammatory diseases, and metabolic disorders. His studies highlight the mechanisms of action of compounds such as rosmarinic acid in cancer cell regulation, the protective effects of rubidium salts in ulcerative colitis, and the role of traditional medicine in enhancing recovery in chronic rhinosinusitis. Additionally, he explores nanomaterials and enzyme microreactors to improve therapeutic stability and efficiency. His multidisciplinary approach integrates pharmacology, molecular biology, and clinical applications to advance healthcare innovation.

Publication Top Notes

  • Bacteriostatic activity and mechanism of minerals containing rubidium
    Year: 2025

  • Traditional Chinese medicine in chronic rhinosinusitis: Mechanisms and postoperative recovery
    Year: 2025 | Citations: 3

  • Rosmarinic acid promotes mitochondrial fission and induces ferroptosis in triple-negative breast cancer cells
    Year: 2025 | Citations: 13

  • Interfacial Stabilization through MOF-Polymer Core-Shell Design: Ultraefficient, Stable and Recyclable Enzymatic Microreactors
    Year: 2025

  • Rubidium salt can effectively relieve the symptoms of DSS-induced ulcerative colitis
    Year: 2024 | Citations: 22

Conclusion

Prof. Zhao Lichun’s outstanding academic achievements, innovative research contributions, and leadership in advancing traditional Chinese medicine and trace element science make him a strong candidate for the Research for Best Researcher Award. With further international expansion of his research collaborations and recognition, he is well-positioned to become a truly global authority in his field.

Prof. Dr. Luis F B B Feitoza | Clinical Sciences | Best Researcher Award

Published on by Global Academic Awards

Prof. Dr. Luis Felipe Feitoza | Clinical Sciences | Best Researcher Award

Prof. Dr. Luis Felipe Feitoza, Kansas State University, United States

Dr. Luis Feitoza is a seasoned veterinarian and academic with a PhD in Veterinary Medicine & Pathobiology. 🐄 He specializes in bovine diagnostics, ruminant nutrition, and feedlot management. 🇺🇸🇧🇷 Trained in Brazil and the U.S., he has served as a Clinical Assistant Professor and research consultant, mentoring graduate students and leading veterinary research. 📊 He’s published on cardiac physiology and drug toxicity, and holds certifications in veterinary ultrasound and data analytics. 🏆 Awarded for both scientific and wildlife photography, he’s also a licensed drone pilot and multilingual communicator.

Publication Profile

Orcid

Google Scholar

🎓 Educational Background

Prof. Dr. Luis F.B.B. Feitoza holds a PhD in Veterinary Medicine & Pathobiology (2023–2024) from Kansas State University 🐄, focusing on veterinary diagnostics and ruminant nutrition. He also earned a Graduate Certificate in Applied Statistics (2018–2022) 📊 and pursued doctoral studies in Animal Sciences emphasizing beef cattle nutrition. Earlier, he received his DVM from the Federal Rural University of Rio de Janeiro (2012–2017) 🇧🇷. Dr. Feitoza also trained at UC Davis in muscle physiology 🧬 and was a visiting scholar at the University of Wisconsin-River Falls (2014–2015) 🇺🇸, where he also completed an English language program

🔬 Research & Work Experience

Prof. Dr. Luis F.B.B. Feitoza currently serves as Graduate School Faculty and Clinical Assistant Professor at the Beef Cattle Institute, Kansas State University 🐂 (2024–present), where he teaches bovine medicine and manages the Feedlot Clinical Rotation. Since 2017, he has worked as a Veterinary Research Consultant across Brazil and the USA 🌎, focusing on herd health, ultrasound diagnostics, and interdisciplinary R&D projects. His previous roles include Research Assistant and Doctorate Researcher (2023–2024), conducting clinical trials, laboratory assays, and data analysis 🔬📈. His work bridges diagnostics, internal medicine, and animal health innovation.

📚 Teaching Experience

Prof. Dr. Luis F.B.B. Feitoza has an extensive teaching background in veterinary and animal sciences 🐄. In 2025, he coordinated the Feedlot Clinical Rotation and lectured on agricultural communication at Kansas State University 🎓. His earlier roles as a Teaching Assistant included Equine Exercise Physiology and Horse Science (2019), where he focused on muscle physiology and equine nutrition 🐎. He also contributed to undergraduate research training (2018) and taught Animal Physiology at UFRRJ in Brazil (2013–2017) 🧬. His hands-on, student-focused approach emphasizes clinical knowledge, research skills, and cross-cultural communication.

🏆 Awards & Recognitions

Prof. Dr. Luis F.B.B. Feitoza has earned multiple accolades recognizing both his scientific and creative contributions 🎖️. He won first place at the IV Annual Meeting of Scientific Initiation (2016) for his work on maternal diet and offspring heart health 🫀. In 2014, he received Honorable Mention at the I Panamerican Congress of Physiological Sciences for research on cardiac adrenoreceptor expression in rats 🧪. Additionally, his photography earned him first and second place awards in the “Outdoor Recreation” and “Other Species” categories in Wild about Kansas by Kansas Wildlife Magazine in 2018

🔬 Research Focus

Prof. Dr. Luis F.B.B. Feitoza’s research spans across veterinary diagnostics, cardiotoxicology, ruminant nutrition, and parasitology 🐄🧬. His work includes studying drug-induced cardiac dysfunction using proteasome and mitochondrial pathways 🫀🧪, nutritional strategies like molasses-based supplementation to improve cattle health 🌾🥩, and parasitic infestations in exotic and wild animals, including first reports of tick species on emus 🦠🦢. He integrates statistical modeling, field diagnostics, and clinical trials to investigate animal health and performance. His interdisciplinary approach bridges veterinary science, physiology, and livestock management, making his research crucial for both animal welfare and agricultural efficiency

Publication Top Notes

📖 Diclofenac induces proteasome and mitochondrial dysfunction in murine cardiomyocytes and hearts – International Journal of Cardiology, 📅 2016 | 🔗 DOI: 10.1016/j.ijcard.2016.08.233 | 📥 Cited by: 77
💊🧬🫀

📖 Ticks in wild animals at a resort and the first documentation of Amblyomma sculptum infesting Emu (Dromaius novaehollandiae) – Revista Brasileira de Parasitologia Veterinária, 📅 2019 | 🔗 DOI: 10.1590/s1984-296120180082 | 📥 Cited by: 9
🦠🦙🌿

📖 PSII-3 Effect of molasses-based block supplementation on cattle fed endophyte-infected Tall Fescue (Festuca arundinacea) seed – Journal of Animal Science, 📅 2019 | 🔗 DOI: 10.1093/jas/skz122.400

📖 Effect of Molasses-Based Block Supplementation on Performance and Welfare of Cattle Fed Infected Tall Fescue seed – Journal article, 📅 2019 | 🔗 DOI: 10.13140/RG.2.2.27430.37442/1

📖 Associations Between Thoracic Ultrasound Chute-Side Evaluations and 60-Day Outcomes in Feedyard Cattle – Veterinary Sciences, 📅 2025 | 🔗 DOI: 10.3390/vetsci12040369

📖 Molasses-Based Block Supplements for Cattle Fed Endophyte-Infected Tall Fescue: Growth & Biomarkers – Animals, 📅 2025 | 🔗 DOI: 10.3390/ani15050717

📖 Targeted durations of tylosin phosphate on liver abscesses in feedlot cattle – Applied Animal Science, 📅 2025 | 🔗 DOI: 10.15232/aas.2024-02574

📖 Targeted thoracic ultrasonography for diagnosing interstitial pneumonia in feedyard cattle – American Journal of Veterinary Research, 📅 2025 | 🔗 DOI: 10.2460/ajvr.24.08.0233

📖 Thoracic Ultrasound in Cattle: Methods, Diagnostics, and Prognostics – Veterinary Sciences, 📅 2025

📖 greatOplus (Extruded Flaxseed & Nannochloropsis) Improves Cattle Performance – KAES Research Reports, 📅 2025

📖 Histologic Characterization of Pulmonary Lesions in Feedlot Cattle Mortalities – Conference Poster, 📅 2024 | 🔗 DOI: 10.13140/RG.2.2.25296.21766

📖 Viability of drone mapping in artisanal fisheries – Sepetiba Bay, Brazil – Ciência Rural, 📅 2024 | 🔗 DOI: 10.1590/0103-8478cr20230167

Sadia Kashif | Pharmacology | Best Researcher Award

Published on by Global Academic Awards

Assist. Prof. Dr. Sadia Kashif | Pharmacology | Best Researcher Award

Assistant Professor at Ziauddin University, Pakistan

Dr. Sadia Suri Kashif is a dedicated pharmacologist and academic with a Ph.D. in Pharmacology from the University of Karachi. With extensive experience in teaching, research, and academic leadership, she currently serves as an Assistant Professor at Ziauddin University. Her work emphasizes interdisciplinary collaboration and the pursuit of impactful research in pharmacology and health sciences. She actively contributes to scholarly publications, supervises M.Phil research, and engages in academic editorial roles. Known for her innovation in herbal fertility treatments, Dr. Sadia continues to inspire future pharmacists through both classroom teaching and cutting-edge research. 🌿📚

Publication Profile

Orcid

Educational Background

Dr. Sadia Suri Kashif holds a Ph.D. in Pharmacology (2024) with a GPA of 4.0 from the University of Karachi, reflecting her academic excellence and commitment to scientific advancement. She earned her M.Phil in Pharmacology from the same institution in 2008 with a GPA of 3.50, and her foundational B. Pharmacy degree in 2003 with a GPA of 3.26. Her educational journey has been marked by distinction and a focus on research-based learning, laying the groundwork for her contributions to pharmacological education and therapeutic research. 🎓📖💊

Professional Background

With over 15 years of academic and research experience, Dr. Sadia Suri Kashif has taught at prestigious institutions like Ziauddin University and Nazeer Hussain University. Currently serving as Assistant Professor since 2017, she teaches Pharmacology, Physiology, and Anatomy, and leads academic publications like PharmaZia and Pharma Vision. Her earlier roles include Lecturer at Jinnah University and freelance research writer. She also interned at Aga Khan University Hospital. Dr. Sadia is widely respected for her teaching, mentoring, and administrative skills in higher education. 👩‍🏫🔬📄

Awards and Honors

Dr. Sadia Suri Kashif has earned recognition for her multifaceted contributions to pharmaceutical education and research. She has presented research at national and international conferences and actively contributes to academic journals as a reviewer for Discover Toxicology and others. Her leadership roles in organizing workshops and conferences, alongside research excellence, have positioned her as a respected voice in pharmacology. She was involved in patent submissions for herbal fertility treatments and has been consistently acknowledged by academic peers for her commitment to innovation and student mentorship. 🏆📜🌟

Research Focus

Dr. Sadia Suri Kashif’s research centers on pharmacological solutions for infertility, depression, and anxiety, with a strong emphasis on animal models and plant-based therapies. Her current projects explore herbal compositions like Allium cepa and Juglans regia for reproductive health. She supervises M.Phil scholars, evaluates antimicrobial agents, and studies neuroactive compounds. Her two-generation studies in rats have received international publication and recognition. With multiple patents under review, her research aims to merge traditional medicine with modern pharmacology for therapeutic advancement. 🌱🧪🧠

Publication Top Notes

1. Fertility‐Enhancing Potential of P. amygdalas and J. regia Oil Mixture in Wistar Rats: Male/Female Infertility Models Assessment
Year: 2025

2. Fertility-enhancing effects of Prunus amygdalas oil on reproductive functions of male rats: A two-generation study
Year: 2025

3. CLINICAL EFFECTIVENESS OF INSULIN GLARGINE & ASPART VERSUS NPH & REGULAR INSULIN RÉGIME IN TYPE 1 DIABETIC PATIENTS OF PAKISTAN
Year: 2024

4. Emerging Role of Medicinal Herbs on Alzheimer’s Disease and Memory Deficits
Year: 2024

5. Depression Review: Factors and Perspectives
Year: 2019

Conclusion

Dr. Sadia Kashif is a highly accomplished researcher in the fields of pharmaceutical and biomedical sciences, with over 25 peer-reviewed publications in reputable journals such as PLOS One, Avicenna Journal of Phytomedicine, and Metabolic Brain Disease. Her work demonstrates exceptional diversity and innovation, focusing on plant-based therapeutics, reproductive pharmacology, and neuroscience, often using both in-vivo and in-vitro models. She has two patents under review related to herbal remedies for reproductive health, reflecting a strong translational impact. In addition to her research productivity, Dr. Kashif is an active academic mentor, journal reviewer, and contributor to scientific forums and editorial platforms. Her interdisciplinary and socially relevant research, combined with her professional engagement and academic service, make her a deserving candidate for the “Best Researcher Award.”

 

 

Julio César Fernández Travieso | Clinical Pharmacology | Best Researcher Award

Published on by Global Academic Awards

Prof. Dr. Julio César Fernández Travieso | Clinical Pharmacology | Best Researcher Award

Prof. Dr. Julio César Fernández Travieso, National Centre for Scientific Research, Cuba

Prof. Dr. Julio César Fernández Travieso is a distinguished Cuban pharmaceutical scientist and Head of the Clinical Trials Unit at the National Centre for Scientific Research in Havana. He earned his BSc in Pharmaceutical Sciences in 1996 and completed his PhD in 2003. As a Senior Researcher and Full Academician of the Cuban Academy of Sciences, he has made significant contributions to the clinical development of natural-origin pharmaceuticals. With over 150 scientific publications and more than 120 conference presentations, his work has had a wide-reaching impact on experimental pharmacology and clinical research in Cuba.

Publication Profile

Scopus

Orcid

🎓 Education

Prof. Dr. Fernández Travieso completed his Bachelor of Science in Pharmaceutical Sciences from Havana University in 1996. He pursued advanced academic training and was awarded a PhD in Pharmaceutical Sciences in 2003. His education provided a comprehensive foundation in experimental pharmacology, pharmaceutical formulation, and clinical research methodologies. These qualifications enabled him to lead major clinical studies and serve in senior research roles. His academic background is firmly rooted in the development of therapeutics derived from natural sources, particularly those innovated in Cuba.

💼 Experience

Dr. Julio César Fernández Travieso currently serves as the Head of the Clinical Trials Unit at the National Centre for Scientific Research, Havana. With a career spanning over two decades, he has led multiple Phase I–IV clinical trials for novel therapeutics developed in Cuba. He is a Senior Investigator specializing in Clinical Pharmacology and has contributed to drug development, safety monitoring, and pharmacodynamic studies. His leadership has enabled the translation of research into approved therapeutic products. He also holds the title of Full Academician of the Cuban Academy of Sciences.

🏅 Awards and Honors

Prof. Dr. Fernández Travieso has received numerous national and international recognitions for his work in pharmaceutical sciences and clinical research. Several of his more than 120 scientific presentations have earned awards at global conferences. His appointment as a Full Academician of the Cuban Academy of Sciences highlights his standing in the scientific community. These honors reflect his role in advancing Cuba’s pharmaceutical innovation, particularly in clinical evaluation and development of natural products. His contributions have positioned him as a scientific leader in Latin America’s biomedical research landscape.

🔍 Research Focus

Dr. Fernández Travieso’s primary research interest lies in experimental pharmacology and conducting Phase I–IV clinical trials of natural-origin pharmaceuticals. He has played a pivotal role in evaluating and validating Cuban-developed products such as Policosanol, Abexol, Prevenox, Vasoactol, and Palmex. His work bridges laboratory pharmacology and clinical application, ensuring rigorous scientific evidence supports therapeutic claims. His research addresses chronic conditions like cardiovascular and metabolic disorders using innovative natural compounds. He also explores drug safety, efficacy, and pharmacokinetics in human populations.

Publication Top Notes

  • Efficacy and Safety of Policosanol (Sugarcane Wax Alcohols) 20 mg/Day in Cuban Prehypertensive Patients: A Randomized, Double-Blind, Multicentre Study 🧑‍⚕️, 2025

  • Comparative Study of the Efficacy and Safety of the Ozonated Sunflower Oil, Ketoconazole and Terbinafine in Patients with Dermatophytosis 💊, 2024

  • Beeswax Alcohol Prevents Low-Density Lipoprotein Oxidation and Demonstrates Antioxidant Activities in Zebrafish Embryos and Human Subjects: A Clinical Study 🧬, Cited by: 6, 2024

  • Effects of Policosanol in Patients with Metabolic Syndrome: A Six-Month Study 💉, Cited by: 6, 2020

  • Efficacy and Tolerability of Roystonea Regia Lipid Extract (D-004) and Terazosin in Men with Symptomatic Benign Prostatic Hyperplasia: A 6-Month Study 🔬, Cited by: 7, 2019

  • Concomitant Use of Policosanol and Antiplatelet Drugs in Older Patients 💊, 2019

  • Non-Cardioembolic Ischemic Stroke Hypertensive Patients, A Therapeutic Hope. Reply 🧠, 2019

 

Garland Kgosi More | Pharmacology | Best Researcher Award

Published on by Global Academic Awards

Dr. Garland Kgosi More | Pharmacology | Best Researcher Award

Dr. Garland Kgosi More, University of South Africa, South Africa

Dr. Garland Kgosi More is a distinguished agricultural scientist specializing in medicinal plant research, particularly in combating infectious diseases. With a PhD in Agriculture from the University of South Africa (UNISA) and a Master’s in Medicinal Plant Sciences from the University of Pretoria (UP), he has made significant contributions to antiviral, antimicrobial, and phytochemical studies. His groundbreaking research on in vitro anti-Rift Valley Fever Virus and medicinal plant metabolomics has earned him international recognition. Currently, Dr. More serves as a Chief Laboratory Technologist and Senior Lecturer at UNISA, contributing to academic excellence through teaching, supervision, and extensive research. His work is widely published in esteemed journals, and he actively mentors postgraduate students. He is passionate about using indigenous knowledge for modern therapeutic solutions and continues to advance global health through innovative scientific inquiry. 🌿🧬

Publication Profile

scopus

Orcid

Google Scholar

🎓 Education

Dr. Garland Kgosi More earned his Doctor of Philosophy in Agriculture from UNISA in 2021, specializing in in vitro anti-Rift Valley Fever Virus research using 1H-NMR metabolomics. His Master of Science in Medicinal Plant Sciences from UP, awarded with distinction in 2013, focused on the antimicrobial constituents of Artemisia afra against periodontal pathogens. In 2007, he completed his Bachelor of Science Honours in Botany, exploring the antimicrobial properties of medicinal plants targeting oral microorganisms. Prior to this, he obtained a Bachelor of Science in Natural/Biological Sciences from UP in 2006, majoring in Botany and Zoology. Committed to professional development, he pursued certifications in Project Management (2020), Hazardous Chemical Substance Handling (2012), HIV/AIDS Awareness (2009), and Occupational Health and Safety Legislation (2008). His interdisciplinary education has equipped him with a robust foundation in agricultural research, biotechnology, and medicinal plant pharmacology. 🧪🌱

💼 Experience

Dr. Garland Kgosi More has over 15 years of academic and research experience. Currently serving as Chief Laboratory Technologist and Senior Lecturer at UNISA, he provides technical expertise, leads laboratory operations, supervises postgraduate students, and conducts high-impact research. He previously held positions as a Laboratory Technologist at UNISA (2014–2023) and Laboratory Technician at UP (2008–2014). In these roles, he managed high-containment laboratories, implemented safety protocols, and supported undergraduate and postgraduate research. His extensive experience includes research project management, laboratory quality control, and the development of standard operating procedures. He has also contributed to health and safety compliance, waste management, and the application of advanced analytical techniques like NMR and UHPLC-MS. Beyond academia, Dr. More actively engages in community outreach projects, promoting scientific knowledge and empowering emerging researchers. His leadership and dedication have significantly advanced agricultural and medicinal plant research. 🧬📊

🏅 Awards and Honors

Dr. Garland Kgosi More has been recognized for his outstanding contributions to agricultural and medicinal plant sciences. His achievements include publishing in prestigious journals like Scientific Reports, Viruses, and MDPI Antioxidants. His doctoral research on antiviral compounds using NMR metabolomics has earned international acclaim. He has received accolades for mentoring postgraduate students and contributing to their successful research publications. Dr. More has served on academic committees, peer-reviewed journals, and research councils, demonstrating academic leadership. He has also presented at numerous international conferences, sharing insights on medicinal plant pharmacology and disease management. His collaborations with multidisciplinary researchers globally further highlight his dedication to scientific advancement. Committed to public health, he has supported projects addressing infectious diseases like HIV and tuberculosis. Dr. More’s accolades exemplify his unwavering commitment to research excellence and societal impact. 🏆🌿

🔎 Research Focus

Dr. Garland Kgosi More’s research revolves around agricultural biotechnology, phytochemistry, and medicinal plant sciences. His primary focus is the identification and analysis of bioactive compounds from medicinal plants for antiviral, antimicrobial, and anti-inflammatory applications. Using advanced metabolomics, including 1H-NMR and UHPLC-MS, he investigates the therapeutic potential of indigenous South African flora. His studies on antiviral agents against the Rift Valley Fever Virus and antimicrobial properties of Artemisia afra have made significant strides in infectious disease management. Additionally, he explores nanotechnology applications in plant-based drug development and investigates the pharmacological effects of nanoparticles synthesized from plant extracts. His multidisciplinary approach includes in silico modeling, molecular docking studies, and cytotoxicity evaluations. Through his extensive research, Dr. More aims to bridge traditional medicine with modern pharmacology, contributing to the discovery of innovative treatments for viral infections and antimicrobial resistance. 🌿🔬

Publication Top Notes

📚 Antimicrobial activity of medicinal plants against oral microorganisms – Cited by 242, 2008 🦷🌿
📚 In-vitro analysis of free radical scavenging activities and suppression of LPS-induced ROS production in macrophage cells by Solanum sisymbriifolium extracts – Cited by 119, 2020 🧪🛡️
📚 Antimicrobial Constituents of Artemisia afra Jacq. ex Willd. against Periodontal Pathogens – Cited by 83, 2012 🌿🦷
📚 Novel silver-platinum bimetallic nanoalloy synthesized from Vernonia mespilifolia extract: Antioxidant, antimicrobial, and cytotoxic activities – Cited by 64, 2020 🧬🦠
📚 Antimicrobial, antioxidant, and cytotoxic properties of biosynthesized copper oxide nanoparticles (CuO-NPs) using Athrixia phylicoides DC – Cited by 46, 2023 🧪🦠
📚 Alkaloids from aerial parts of Annona senegalensis against Streptococcus mutans – Cited by 41, 2017 🌿🧬
📚 A review of the ethnopharmacology, phytochemistry and pharmacological relevance of the South African weed Solanum sisymbriifolium Lam. (Solanaceae) – Cited by 29, 2019 📖🌱
📚 Synthesis of furocoumarin–stilbene hybrids as potential multifunctional drugs against multiple biochemical targets associated with Alzheimer’s disease – Cited by 23, 2020 🧠💊
📚 Metabolomic profile of medicinal plants with anti-RVFV activity – Cited by 19, 2022 🦠🧬
📚 Metabolomic Profiling of Antioxidant Compounds in Five Vachellia Species – Cited by 18, 2021 🌳🛡️
📚 In vitro evaluation of anti-Rift Valley Fever Virus, antioxidant and anti-inflammatory activity of South African medicinal plant extracts – Cited by 18, 2021 🦠🧪
📚 Lithium inhibits NF-κB nuclear translocation and modulates inflammation profiles in Rift Valley Fever virus-infected Raw 264.7 macrophages – Cited by 16, 2021 🧫🛡️
📚 Bio-synthesized calcium carbonate (CaCO3) nanoparticles: Their anti-fungal properties and application as nanofertilizer on Lycopersicon esculentum growth and gas exchange – Cited by 14, 2023 🍅🌿
📚 Design, synthesis and evaluation of the 2′-hydroxy-3′-iodo-5′-nitrochalcones for cytotoxicity (MCF-7 & A549) and potential to inhibit tyrosine kinase (VEGFR-2) activity – Cited by 12, 2024 🧪🧬
📚 Antimicrobial, cytotoxic and oxidative stress inhibitory activities of terpenoids and flavonols from Senegalia nigrescens (Oliv.) PJH Hurter – Cited by 9, 2021 🌿🧫

Conclusion 🏆

Dr. Garland Kgosi More is a highly suitable candidate for the Best Researcher Award. His exceptional academic background, impactful research in antiviral and antimicrobial compounds, significant publication record, commitment to student mentorship, and leadership in scientific research position him as a strong contender for this prestigious recognition.

Neda Shakour | Medicinal chemistry | Best Researcher Award

Published on by Global Academic Awards

Dr. Neda Shakour | Medicinal chemistry | Best Researcher Award

Dr. Neda Shakour, Mashhad University of Medical Science, Iran

Dr. Neda Shakour is a distinguished medicinal chemist at Mashhad University of Medical Sciences, specializing in drug design for diabetes treatment. With a Ph.D. in Medicinal Chemistry, her research focuses on thiazolidinediones and in silico drug discovery. She has extensive teaching experience and has contributed to regulatory work at the Food and Drug Administration of Mashhad. Recognized with numerous awards and research grants, Dr. Shakour has published extensively on cancer therapies, metabolic diseases, and nanomedicine, making significant advancements in medical science. 🏆🔬

Publication Profile

Google Scholar

🎓 Education

Dr. Neda Shakour earned her Ph.D. in Medicinal Chemistry from Mashhad University of Medical Sciences, focusing on designing and synthesizing novel thiazolidinediones for diabetes treatment. She completed her M.Sc. in Organic Chemistry at the University of Zanjan, where she specialized in nanoscale compound synthesis. Her academic journey began with a B.Sc. in Chemistry from Islamic Azad University of Shahreza. Throughout her studies, Dr. Shakour demonstrated exceptional research capabilities, gaining recognition for her contributions to medicinal chemistry. 📘🧪

👩‍🏫 Experience

Dr. Neda Shakour has over a decade of teaching experience at institutions like the Non-Profit Institute of the Role of the World in Isfahan, Shahreza University, and Borujen University. From 2021 to 2023, she worked as a postdoctoral researcher at Mashhad University of Medical Sciences, specializing in drug discovery. Currently, she is actively contributing to the Food and Drug Administration of Mashhad, where she applies her expertise in medicinal chemistry to enhance drug regulation and healthcare policies. 📚🔎

🏅 Awards and Honors

Dr. Neda Shakour was awarded the Level 3 Research and Innovation Credit by the National Elite Foundation in 2010. In 2024-2025, she secured prestigious research grants for two groundbreaking projects on non-peptide GLP-1R natural agonists and kidney failure treatments. Her consistent recognition for research excellence underscores her impact in drug discovery and diabetes management. With her dedication to innovation, Dr. Shakour remains a leader in medicinal chemistry research. 🥇🔬

🔍 Research Focus

Dr. Neda Shakour’s research spans the design, synthesis, and biological evaluation of organic compounds, particularly thiazolidinediones for diabetes treatment. She specializes in in silico drug discovery, biomimetic synthesis, and the development of targeted therapies for metabolic diseases. Her work also addresses cancer treatments and fibrosis management, demonstrating a commitment to improving patient outcomes. Dr. Shakour’s research significantly advances therapeutic innovation in pharmaceutical science. 💡🧪

Publication Top Notes

  • 📖 The natural phenolic compounds as modulators of NADPH oxidases in hypertension – Phytomedicine 55, 200-213 – Cited by: 176 – Year: 2019 🌿

  • 📖 Statins and C-reactive protein: in silico evidence on direct interaction – Archives of Medical Science 16 (6), 1432-1439 – Cited by: 60 – Year: 2020 💊

  • 📖 Ethnobotany, Phytochemistry and Pharmacological Features of Centella asiatica: A Comprehensive Review – Pharmacological Properties of Plant-Derived Natural Products – Cited by: 35 – Year: 2021 🌱

  • 📖 Docetaxel encapsulation in nanoscale assembly micelles for targeted metastatic breast cancer therapy – International Journal of Pharmaceutics 605, 120822 – Cited by: 31 – Year: 2021 🧬

  • 📖 In silico evidence of direct interaction between statins and β‐amyloid – Journal of Cellular Biochemistry 120 (3), 4710-4715 – Cited by: 23 – Year: 2019 🧠

  • 📖 Cellulose-based nanofibril composite materials for bacterial infection control – Frontiers in Bioengineering and Biotechnology 9, 732461 – Cited by: 22 – Year: 2021 🦠

  • 📖 Design, synthesis and biological evaluation of novel thiazolidinediones as antidiabetic agents – Bioorganic Chemistry 115, 105162 – Cited by: 20 – Year: 2021 🍎

  • 📖 Data mining approaches to explore the association between type 2 diabetes mellitus with SARS-CoV-2 – BMC Pulmonary Medicine 23 (1), 1-14 – Cited by: 19 – Year: 2023 🩸

  • 📖 Candesartan inhibits tumor growth and fibrosis in colorectal cancer – Excli Journal 20, 863 – Cited by: 17 – Year: 2021 🧑‍⚕️

  • 📖 Dual targeting of TGF-β and PD-L1 in colorectal carcinoma – Life Sciences 328, 121865 – Cited by: 13 – Year: 2023 🧫

 

 

Chang Wang | Pharmacokinetic | Best Researcher Award

Published on by Global Academic Awards

Mr. Chang Wang | Pharmacokinetic | Best Researcher Award

Mr. Chang Wang, The Second Hospital & Clinical Medical School, Lanzhou University, China

Mr. Chang Wang is a dedicated Pharmacist In-Charge at Lanzhou University’s Second Hospital. He holds a Doctor of Medicine candidacy in Traditional Chinese Pharmacy from Gansu University of Chinese Medicine. His expertise spans therapeutic drug monitoring and clinical pharmacology, with significant contributions in drug interactions and high-altitude pharmacology. Mr. Wang has published widely, including in the Journal of Chromatography B and Journal of Mass Spectrometry. He has received the First Prize for Military Scientific and Technological Progress and is an active member of several professional societies, including the International Association of Therapeutic Drug Monitoring. 💊📚

 

Publication Profile

Scopus

Educational Background 🎓

Mr. Chang Wang is currently pursuing a Doctor of Medicine in Traditional Chinese Pharmacy at Gansu University of Chinese Medicine (2024-present). He earned his Master of Pharmacy from Lanzhou University, School of Pharmacy (2012-2015), where he deepened his expertise in pharmaceutical sciences. Prior to that, he completed his Bachelor of Science in Pharmacy at Lanzhou University, School of Pharmacy (2008-2012). Mr. Wang’s solid educational foundation has enabled him to advance his career as a clinical pharmacist and contribute significantly to the field of therapeutic drug monitoring and clinical pharmacology. 💊📚

 

 

Academic Positions 🏥

Mr. Chang Wang currently serves as the Pharmacist In-Charge at the Department of Pharmacy in the Second Hospital & Clinical Medical School, Lanzhou University (2019-present), where he plays a key role in clinical pharmacy operations. Prior to this, he worked as a Pharmacist at the Department of Pharmacy, 940 Hospital, Joint Service Support Force of the Chinese People’s Liberation Army (2015-2018). His extensive experience in both academic and military healthcare settings has strengthened his expertise in pharmacology, therapeutic drug monitoring, and clinical pharmacy practice. 💉💊

 

 

Research Focus

Mr. Chang Wang’s research primarily revolves around pharmacology, drug monitoring, and pharmacokinetics. His work includes developing advanced analytical methods, such as UPLC–MS/MS for quantifying drugs like polymyxins and caspofungin for therapeutic drug monitoring. He has contributed significantly to understanding the regulation mechanisms of drug-metabolizing enzymes and transporters, especially in hypoxia and high-altitude environments. His studies also explore the impact of intestinal microflora on drug metabolism, renal excretion, and drug efficacy under varying physiological conditions. Mr. Wang’s research is pivotal in advancing personalized medicine and drug therapy. 💉🧬

 

 

Publication Top Notes

  • Development and validation of a UPLC–MS/MS method for simultaneous quantification of polymyxins and caspofungin in human plasma for therapeutic drug monitoring – Wu, T., Pu, L., Liu, W., Wang, C., Qiu, W. (2025) 📅
  • Modulation of drug-metabolizing enzymes and transporters under hypoxia environment – Min, Q., Feng, S.-L., Lu, H., Wang, R., Zhang, J.-H., Wang, C. (2019) – Cited by 3 📖
  • Effects of intestinal microflora on drug metabolism – Chen, Y.-Y., Wang, R., Zhang, J.-H., Wang, C., Sun, Y.-M. (2019) – Cited by 5 💊
  • Potential regulation mechanisms of P-gp in the blood-brain barrier in hypoxia – Ding, Y., Wang, R., Zhang, J., Wang, C., Yuan, X. (2019) – Cited by 15 🧠
  • Plasma proteomic study of acute mountain sickness susceptible and resistant individuals – Lu, H., Wang, R., Li, W., Sun, Y., Jia, Z. (2018) – Cited by 19 ⛰️
  • Research progress of long chain non-coding RNA H19 in anoxic environment mechanism – Yue, X., Wang, R., Li, W., Lu, H., Zhang, J. (2018) – Cited by 1 🧬
  • Interaction of amoxicillin and nifedipine mediated by intestinal flora – Zhang, J.-H., Zhang, J.-M., Wang, R., Zhao, A.-P., Jia, Z.-P. (2018) – Cited by 5 💊
  • Research progress on clinical gene polymorphism of clopidogrel resistance – Sun, Y.-M., Cui, M.-X., Li, W.-B., Wang, C., Wang, R. (2018) – Cited by 3 🧬
  • Evaluation of renal excretion and pharmacokinetics of furosemide in rats after acute exposure to high altitude at 4300 m – Luo, B., Li, J., Yang, T., Zhao, A., Wang, R. (2018) – Cited by 11 🌄
  • Advances of studies on effect of drug transporter under hypoxia – Zhang, M.-X., Wang, R., Xu, W.-B., Liu, J.-J., Jia, Z.-P. (2018) – Cited by 5 💉

 

 

Hatice Yesim Karasulu | Pharmacology | Excellence in Research

Published on by Global Academic Awards

Hatice Yesim Karasulu | Pharmacology | Excellence in Research

Prof Hatice Yesim Karasulu, Ege University, Turkey

Prof. Dr. Hatice Yesim Karasulu is a renowned pharmaceutical technology expert at Ege University, Turkey. With a Ph.D. in Pharmaceutical Technology, she became an Associate Professor in 2006 and a Professor in 2011. She is a consultant at Ege University’s Center for Drug Research & Development (ARGEFAR). Dr. Karasulu’s research focuses on colloidal drug delivery systems like liposomes, nanoparticles, and emulsions. She has over 50 publications, 2 patents, and several industry collaborations. Additionally, she has authored multiple book chapters and received various grants. 🌍💊📚🔬💡

Publication Profile

google scholar

Academic and Professional Background

Prof. Dr. Hatice Yesim Karasulu is a renowned academic and consultant in pharmaceutical technology. With a Ph.D. from the University of Ege, she became an Associate Professor in 2006 and a Professor in 2011. She currently consults at Ege University’s Center for Drug Research & Development (ARGEFAR). Dr. Karasulu’s research focuses on colloidal drug delivery systems such as liposomes and nano/microparticles. She has published over 50 papers, authored five book chapters, and holds two patents related to nano-drug delivery systems. Her collaborative projects with universities and the pharmaceutical industry aim to innovate drug delivery. 🧪📚

Research and Innovations

Prof. Hatice Yesim has conducted extensive research on drug delivery systems, particularly through EU and TUBITAK-funded projects. Her studies focus on the development of microemulsion formulations, bioadhesive systems, and surfactant effects for enhanced drug bioavailability. Notable projects include investigations on skin absorption, nasal drug diffusion, and the creation of transdermal systems for various drugs such as naproxen and terbutaline sulphate. Additionally, Prof. Yesim has explored the use of PEG-PLA-PGA triblock micelles for cancer treatments and innovative dry powder inhalers for asthma management. Her work contributes significantly to improving drug delivery technologies for targeted therapies. 🌟👩‍🔬

Books and Patents

Prof. Hatice Yesim Karasulu is a distinguished academic and researcher, known for her contributions to pharmaceutical sciences. As an author of several influential book chapters, she has published with leading publishers like Elsevier, Taylor & Francis, and InTech. Prof. Karasulu holds multiple patents, including innovative nano-drug delivery systems, with both national and international applications. Her work exemplifies a seamless integration of cutting-edge research and practical solutions, especially in the pharmaceutical industry. Her contributions continue to impact the development of new drug delivery technologies. 📚💡💊🌍

Industry Projects

Prof. Hatice Yesim’s research focuses on the development of products aimed at improving the quality of life for psoriasis patients. Her work involves conducting clinical trials and preparing submissions for approval, such as those to the Ministry of Health in CTD format. The primary goal of her research is to create effective solutions for managing psoriasis, a chronic skin condition, and to enhance patient outcomes through innovative treatments. This aligns with areas of dermatology, clinical trials, and health innovation. Her research significantly contributes to improving patient care and advancing medical treatments for dermatological conditions. 🧴🩺💊🧑‍🔬

Research Focus

Prof. Hatice Yesim Karasulu’s research focuses on pharmaceutical formulations and drug delivery systems, with a particular emphasis on transdermal delivery, microemulsions, and lipophilic microspheres. Her work explores the skin permeation, anti-inflammatory effects, and analgesic properties of various formulations like diclofenac sodium and naproxen. She has also studied the toxicity, stability, and applications of microemulsions as novel drug carriers. Additionally, her research includes the pharmacokinetics of drugs, modeling drug release, and the use of bioadhesive formulations in vaginal and nasal drug delivery systems. 💊📦💉💡🌱

Publication Top Notes

Transdermal delivery of diclofenac sodium through rat skin from various formulations

Evaluation of skin permeation and anti-inflammatory and analgesic effects of new naproxen microemulsion formulations

Microemulsions as novel drug carriers: the formation, stability, applications and toxicity

Comparison of different water/oil microemulsions containing diclofenac sodium: preparation, characterization, release rate, and skin irritation studies

Extended release lipophilic indomethacin microspheres: formulation factors and mathematical equations fitted drug release rates

Modeling of theophylline release from different geometrical erodible tablets

Efficacy of a new ketoconazole bioadhesive vaginal tablet on Candida albicans